Literature DB >> 2656524

Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens.

A Molla1, T Akaike, H Maeda.   

Abstract

The interaction of the 56-kilodalton (kDa) proteinase from Serratia marcescens with human plasma activated C1 (C1) inhibitor, alpha 2-antiplasmin, and antithrombin III was investigated. The 56-kDa proteinase was not affected by these inhibitors; on the contrary, all the inhibitors were inactivated by the 56-kDa proteinase within 2 to 6 h. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicated that all three inhibitors showed decreases in molecular weight of approximately 8,000 to 10,000 as a result of proteolytic cleavage by the 56-kDa proteinase. The 56-kDa proteinase also inactivated serum complement within 2 to 6 h. The loss of inhibitory activity caused by the 56-kDa proteinase, together with the effects of endogenous serine proteinases, may facilitate tissue destruction and inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656524      PMCID: PMC313371          DOI: 10.1128/iai.57.6.1868-1871.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study.

Authors:  D G Maki; C G Hennekens; C W Phillips; W V Shaw; J V Bennett
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

2.  Activation of plasminogen by human plasma kallikrein.

Authors:  R W Colman
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

3.  Biochemical mechanisms of generation of bradykinin by endotoxin.

Authors:  R L Miller; M J Reichgott; K L Melmon
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Inactivation of human plasma alpha 1-proteinase inhibitor by a metalloproteinase from Serratia marcescens.

Authors:  G D Virca; D Lyerly; A Kreger; J Travis
Journal:  Biochim Biophys Acta       Date:  1982-06-04

5.  Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate.

Authors:  M J Griffith
Journal:  Thromb Res       Date:  1982-02-01       Impact factor: 3.944

6.  Assay of proteolytic enzymes by the fluorescence polarization technique.

Authors:  H Maeda
Journal:  Anal Biochem       Date:  1979-01-01       Impact factor: 3.365

7.  Inhibitory spectrum of alpha 2-plasmin inhibitor.

Authors:  H Saito; G H Goldsmith; M Moroi; N Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Correlation of in vivo and in vitro inhibition of thrombin by plasma inhibitors.

Authors:  C N Vogel; H S Kingdon; R L Lundblad
Journal:  J Lab Clin Med       Date:  1979-04

9.  The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.

Authors:  J Edy; D Collen
Journal:  Biochim Biophys Acta       Date:  1977-10-13

10.  Hormone binding globulins undergo serpin conformational change in inflammation.

Authors:  P A Pemberton; P E Stein; M B Pepys; J M Potter; R W Carrell
Journal:  Nature       Date:  1988-11-17       Impact factor: 49.962

View more
  10 in total

Review 1.  Bacterial extracellular zinc-containing metalloproteases.

Authors:  C C Häse; R A Finkelstein
Journal:  Microbiol Rev       Date:  1993-12

Review 2.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

Review 3.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Molecular characterization of protease activity in Serratia sp. strain SCBI and its importance in cytotoxicity and virulence.

Authors:  Lauren M Petersen; Louis S Tisa
Journal:  J Bacteriol       Date:  2014-09-02       Impact factor: 3.490

5.  Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease.

Authors:  T Oda; Y Kojima; T Akaike; S Ijiri; A Molla; H Maeda
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist.

Authors:  K Maruo; T Akaike; T Ono; H Maeda
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 7.  Protease-dependent mechanisms of complement evasion by bacterial pathogens.

Authors:  Michal Potempa; Jan Potempa
Journal:  Biol Chem       Date:  2012-09       Impact factor: 3.915

8.  Degradation of humoral host defense by Candida albicans proteinase.

Authors:  H Kaminishi; H Miyaguchi; T Tamaki; N Suenaga; M Hisamatsu; I Mihashi; H Matsumoto; H Maeda; Y Hagihara
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

9.  Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.

Authors:  Wyndham W Lathem; Tessa Bergsbaken; Rodney A Welch
Journal:  J Exp Med       Date:  2004-04-19       Impact factor: 14.307

10.  Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.

Authors:  André Weiss; Hanna Joerss; Jens Brockmeyer
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.